What is go.drugbank.com?
Founded in 2006 and headquartered in Alberta, Canada, DrugBank operates as a premier bioinformatics and cheminformatics resource. The platform provides an exhaustive database that integrates detailed drug information with comprehensive drug target data, serving as a critical utility for researchers, clinicians, and pharmaceutical developers. By synthesizing disparate data points into a structured, machine-readable format, DrugBank facilitates accelerated drug discovery and precision medicine workflows. Its market position is defined by its role as an essential data layer for modern healthcare innovation, enabling stakeholders to navigate the complexities of pharmacology with unprecedented accuracy and speed.
How much funding has go.drugbank.com raised?
go.drugbank.com has raised a total of $9M across 1 funding round:
Angel/Seed
$9M
Angel/Seed (2022): $9M with participation from Amplitude Ventures and Brightspark Ventures
Key Investors in go.drugbank.com
Amplitude Ventures
A venture capital firm focused on building Canadian companies with world-class management teams, specifically targeting the precision medicine sector.
Brightspark Ventures
A long-standing Canadian venture capital firm that provides growth capital and strategic expertise to disruptive, market-transforming technology companies.
What's next for go.drugbank.com?
Looking ahead, the strategic deployment of this capital will likely focus on scaling the company's data processing capabilities and enhancing its enterprise-grade API offerings. As the industry shifts toward data-driven drug development, DrugBank is poised to capitalize on the increasing need for reliable, curated datasets that support AI-driven research and clinical decision-making. The company's roadmap suggests a continued commitment to expanding its cheminformatics footprint, potentially exploring new partnerships within the precision medicine sector to further integrate its data into the clinical pipeline. This growth phase is expected to solidify its status as an indispensable asset for global pharmaceutical enterprises.
See full go.drugbank.com company page
